Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

1.

Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.

Reboredo M, Chang HC, Barbero R, Rodríguez-Ortigosa CM, Pérez-Vizcaíno F, Morán A, García M, Banales JM, Carreño N, Alegre F, Herrero I, Quiroga J, Prieto J, Sangro B.

PLoS One. 2013;8(1):e52683. doi: 10.1371/journal.pone.0052683. Epub 2013 Jan 16.

PMID:
23341903
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.

Reiberger T, Payer BA, Schwabl P, Hayden H, Horvatits T, Jäger B, Hummel T, Mitterhauser M, Trauner M, Fuhrmann V, Angermayr B, Peck-Radosavljevic M; Vienna Hepatic Hemodynamic Lab.

Liver Int. 2013 Apr;33(4):561-8. doi: 10.1111/liv.12101. Epub 2013 Jan 20.

PMID:
23331709
[PubMed - indexed for MEDLINE]
3.

Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.

Moleda L, Trebicka J, Dietrich P, Gäbele E, Hellerbrand C, Straub RH, Sauerbruch T, Schoelmerich J, Wiest R.

Gut. 2011 Aug;60(8):1122-32. doi: 10.1136/gut.2010.226407. Epub 2011 Feb 12.

PMID:
21317421
[PubMed - indexed for MEDLINE]
4.

Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol.

Lebrec D, Moreau R, Cailmail S, Sogni P, Oberti F, Hadengue A.

J Hepatol. 1993 Jan;17(1):102-7.

PMID:
8445208
[PubMed - indexed for MEDLINE]
5.

Effects of the combined administration of propranolol plus sorafenib on portal hypertension in cirrhotic rats.

D'Amico M, Mejías M, García-Pras E, Abraldes JG, García-Pagán JC, Fernández M, Bosch J.

Am J Physiol Gastrointest Liver Physiol. 2012 May 15;302(10):G1191-8. doi: 10.1152/ajpgi.00252.2011. Epub 2012 Mar 8.

PMID:
22403792
[PubMed - indexed for MEDLINE]
Free Article
6.

Noninvasive hemodynamic measurements of superior mesenteric artery in the prediction of portal pressure response to propranolol.

Iwao T, Oho K, Sakai T, Sato M, Nakano R, Yamayaki M, Toyonaga A, Tanikawa K.

J Hepatol. 1998 May;28(5):847-55.

PMID:
9625321
[PubMed - indexed for MEDLINE]
7.

Haemodynamic effects of combined treatment with molsidomine and propranolol on portal hypertension in conscious and unrestrained cirrhotic rats.

Hori N, Okanoue T, Sawa Y, Mori T, Kashima K.

J Gastroenterol Hepatol. 1996 Oct;11(10):985-92.

PMID:
8912139
[PubMed - indexed for MEDLINE]
8.

Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats.

Heller J, Shiozawa T, Trebicka J, Hennenberg M, Schepke M, Neef M, Sauerbruch T.

Eur J Clin Invest. 2003 Nov;33(11):1006-12.

PMID:
14636305
[PubMed - indexed for MEDLINE]
9.

Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk in cirrhotic patients.

Colle I, De Vriese AS, Van Vlierberghe H, Lameire NH, DeVos M.

Liver Int. 2004 Feb;24(1):63-8.

PMID:
15102002
[PubMed - indexed for MEDLINE]
10.

Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.

Coll M, Rodriguez S, Raurell I, Ezkurdia N, Brull A, Augustin S, Guardia J, Esteban R, Martell M, Genescà J.

Hepatology. 2012 Nov;56(5):1849-60. doi: 10.1002/hep.25845. Epub 2012 Oct 14.

PMID:
22610782
[PubMed - indexed for MEDLINE]
11.

Hemodynamic and metabolic effects of terlipressin in patients with cirrhosis receiving a nonselective beta-blocker.

Vachiery F, Moreau R, Gadano A, Yang S, Sogni P, Hadengue A, Cailmail S, Soupison T, Lebrec D.

Dig Dis Sci. 1996 Sep;41(9):1722-6.

PMID:
8794785
[PubMed - indexed for MEDLINE]
12.

Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats.

Pizcueta MP, de Lacy AM, Kravetz D, Bosch J, Rodés J.

Hepatology. 1989 Dec;10(6):953-7.

PMID:
2583690
[PubMed - indexed for MEDLINE]
13.
14.
15.

Prevention of portal hypertension by propranolol and spironolactone in rats with bile duct ligation.

Oberti F, Rifflet H, Maïga MY, Pilette C, Gallois Y, Douay O, Le Jeune JJ, Saumet JL, Calès P.

J Hepatol. 1997 Jan;26(1):167-73.

PMID:
9148008
[PubMed - indexed for MEDLINE]
16.

Hemodynamic effects of combined treatment with somatostatin analogue (SMS 201-995) and low-dose isosorbide dinitrate on portal hypertension in conscious cirrhotic rats.

Hori N, Okanoue T, Sawa Y, Itoh Y, Mori T, Takami S, Kashima K.

J Gastroenterol. 1994 Aug;29(4):460-8.

PMID:
7951857
[PubMed - indexed for MEDLINE]
17.

Role of cirrhosis in the hemodynamic response to hemorrhage in portal hypertension.

Burns RC, Wu Y, Sitzmann JV.

Surgery. 1995 May;117(5):488-93.

PMID:
7740418
[PubMed - indexed for MEDLINE]
18.

Hemodynamic effects of eight-day octreotide and propranolol administration in portal hypertensive rats.

Huang YT, Cheng YR, Lin HC, Hou MC, Lee SD, Hong CY.

Dig Dis Sci. 1998 Feb;43(2):358-64.

PMID:
9512131
[PubMed - indexed for MEDLINE]
19.

Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rat model of portal hypertension: role of nitric oxide and bradykinin.

Chen CT, Chu CJ, Lee FY, Chang FY, Wang SS, Lin HC, Hou MC, Wu SL, Chan CC, Huang HC, Lee SD.

Hepatogastroenterology. 2009 Sep-Oct;56(94-95):1261-7.

PMID:
19950773
[PubMed - indexed for MEDLINE]
20.

Beneficial effects of combined terlipressin and tetramethylpyrazine administration on portal hypertensive rats.

Chang FC, Huang YT, Lin HC, Hong CY, Lin JG, Chen KJ.

Can J Physiol Pharmacol. 1999 Aug;77(8):618-24.

PMID:
10543725
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk